Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063237) titled 'MRGPRX2 variants and anaphylaxis' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Gunma University
Condition:
Condition - Anaphylaxis
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - The aim of this study is to investigate MRGPRX2 genetic variants in patients with anaphylaxis and to explore whether these variants are associated with the development and severity of anaphylaxis.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - Patients undergoing diagnostic testing to identify...